CAP Molecular Diagnosis of Lung Cancer: Revision history

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

12 August 2015

  • curprev 13:2713:27, 12 August 2015 Tate talk contribs 2,766 bytes +2,766 Created page with " {{hidden|List 5 treatment defining molecular transformation, the neoplasm, and the genetic alteration|1. 100% of CML: BRR-ABL > Imatinib, 2. 20% of Lung Adenocarcinoma: EGFR..."